FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/10/021726 [Registered on: 21/10/2019] Trial Registered Prospectively
Last Modified On: 18/10/2019
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective Observational study 
Study Design  Other 
Public Title of Study   A study to capture the patient characteristics, practices of treatment and observation measures used to maintain the blood pressure in patient presenting with early infection and low blood pressure.  
Scientific Title of Study   Hemodynamic resuscitation and monitoring in early sepsis(HERMES Study) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Protocol_No_3364_Version_1.0 dated 09 July 2019  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anesthesia, Critical care and pain, Main Building, Dr.E Borges Road,Parel, Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrSheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anesthesia, Critical care and pain, Main Building, Dr.E Borges Road,Parel, Mumbai


MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  DrSheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anesthesia, Critical care and pain, Main Building, Dr.E Borges Road,Parel, Mumbai


MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Source of Monetary or Material Support  
Indian Society of Critical Care Medicine Unit 13-14,1st Floor,Hind Service Indus Premises Co.op Soc.Off VeerSavarkar Marg,Dadar,Mumbai-400028  
 
Primary Sponsor  
Name  Indian Society of Critical Care Medicine 
Address  Unit 13-14,1st Floor,Hind Service Indus Premises Co.op Soc.Off VeerSavarkar Marg,Dadar,Mumbai-400028  
Type of Sponsor  Other [non-profit association of Indian Physicians, Nurses,& allied health care professionals] 
 
Details of Secondary Sponsor  
Name  Address 
Tata Memorial Hospital  Dr.E Borges Road, Parel, Mumbai-12 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSheila Nainan Myatra  Tata Memorial Hospital  Room no MB-117 and MB-217, Intensive care units,Main Building Department of Anesthesiology Critical care and Pain,Dr.E Borges road, Parel, Mumabi
Mumbai
MAHARASHTRA 
9820156070

sheila150@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R652||Severe sepsis, (2) ICD-10 Condition: R579||Shock, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Adult patients (≥ 18 years old)
2. Presenting to ICU with suspected sepsis
3. Presence of hypotension (Systolic BP ≤ 90 mmHg / Mean arterial pressure (MAP) ≤ 65mmhg or patient with Systolic BP > 90 mmHg / MAP >65mmHg on vasopressor 
 
ExclusionCriteria 
Details  1. Patient likely to be in shock due to reason other than sepsis (e.g. cardiogenic, hemorrhagic shock etc.)
2. Decision taken for not intubating / ventilating /aggressive resuscitation prior to ICU admission
3. Patient transferred from another hospital admitted for more than 7days
4. Patient transferred from another ICU 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.ICU Mortality
2.Sepsis resuscitation goals achieved in 1 hour 
Once after completion of study. 
 
Secondary Outcome  
Outcome  TimePoints 
Hospital mortality  Once after completion of study. 
28-day mortality  Once after completion of study. 
Sepsis resuscitation goals achieved in 3 hour  Once after completion of study. 
Sepsis resuscitation goals achieved in 6 hour  Once after completion of study 
 
Target Sample Size   Total Sample Size="500"
Sample Size from India="500" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/10/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

“Hemodynamic Resuscitation and Monitoring in Early Sepsis (HERMES Study)” involves recording of patient’s medical data related to that has been collected as part of his/her routine medical care in ICU.

Presently there is no data from Indian ICUs on the way patients in early sepsis are resuscitated and monitored. There may exist a wide variation in clinical practice. We would like to conduct an observational study in various levels of Indian ICUs, to prospectively collect data on adult patients admitted to ICU with early sepsis in a 60-day window period. We would like to study the hemodynamic resuscitation and monitoring performed in these patients. In addition, we would like to identify factors associated with improved outcomes and achieving the goals of the sepsis bundles in one, three and six hours.

 

The objectives of the study are as follows

  • To capture the patient characteristics and hemodynamic resuscitation and monitoring practices in patients presenting with early sepsis and hypotension to Indian ICUs
  • To determine various factors associated with improved survival in patients with septic shock
  • To determine factors associated with achieving the resuscitation goals of the sepsis bundle within1 hour, 3 hours and 6 hours in patients with septic shock

 

We plan to recruit 50 -100 centers nationwide. Each center will be asked to collect data from at least 10 patients in a maximum time window of 60 days. A convenience sample of minimum 500 patients presenting to ICU with suspected sepsis and hypotension will be taken.

Each center will select a start date anytime between 1 st August to 1st October 2019 and will collect data within 60 days of the start date. The study will end anytime between 30th September and 29th November 2019, depending on the start date. All consecutive patients in the 60-day period will be screened and those eligible will be enrolled.

There will be no direct patient contact or intervention. Local coordinators will guarantee the integrity of data collection and ensure timely completion of CRFs.

 

This is an ISCCM Research Committee funded study. The ISCCM will fund the PI institution for all expenses related software development, website hosting, secretarial assistance and miscellaneous expenses related to the conduct of the study, data analysis and publication (against actual bills). No funding will be given to the investigators from the various participating centres for contributing data. 
Close